Meredith Cook - Nov 13, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SR. VP, GENERAL COUNSEL & SEC.
Signature
/s/ Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Nov 13, 2023
Transactions value $
-$13,008
Form type
4
Date filed
11/14/2023, 05:04 PM
Previous filing
Jul 19, 2023
Next filing
Dec 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$13K -250 -0.66% $52.03 37.5K Nov 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.